Insilico Medicine (HKG:3696) will be added to the FTSE Global Equity Index Series following FTSE Russell's quarterly review, according to a Monday Hong Kong bourse filing.
The artificial intelligence drug discovery company will join the FTSE Global Small Cap Index, FTSE Global All Cap Index, and FTSE Global Total Cap Index, with the changes taking effect on June 22.